Omada Health (OMDA) director granted 1,299 RSUs in lieu of fees

Rhea-AI Filing Summary

HILLEMAN JERYL L reported acquisition or exercise transactions in this Form 4 filing.

Omada Health, Inc. director Jeryl L. Hilleman received an equity award rather than making a market purchase. She was granted 1,299 restricted stock units under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share of common stock, to be settled on a future date as provided by the program. Following this grant, she holds 26,519 shares of Omada Health common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HILLEMAN JERYL L

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,299	$0.00	--

Holdings After Transaction: Common Stock — 26,519 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 1,299 units Shares per RSU: 1 share Post-grant holdings: 26,519 shares +1 more

4 metrics

RSUs granted 1,299 units Non-Employee Director Compensation Program grant in lieu of retainer fees

Shares per RSU 1 share Each RSU represents one share of Omada Health common stock

Post-grant holdings 26,519 shares Total Omada Health common stock held directly after RSU grant

Grant price per share $0.00 Equity award granted as compensation, not a market purchase

Key Terms

restricted stock units, Non-Employee Director Compensation Program, retainer fees, Common Stock

4 terms

restricted stock units financial

"Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Non-Employee Director Compensation Program financial

"were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

retainer fees financial

"granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

Common Stock financial

"Each RSU represents the right to receive one (1) share of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/07/2026 - 07:26 PM Accepted by SEC EDGAR 07/07/2026 - 07:26 PM Learn about SEC filing dates

FAQ

What did Omada Health (OMDA) director Jeryl Hilleman receive in this Form 4?

Jeryl L. Hilleman received an award of 1,299 restricted stock units. These RSUs are part of Omada Health’s Non-Employee Director Compensation Program and were granted in lieu of cash retainer fees for her board service.

Is the Omada Health (OMDA) Form 4 transaction a stock purchase or compensation grant?

The Form 4 shows a compensation grant, not an open-market stock purchase. Director Jeryl Hilleman received 1,299 restricted stock units as part of the company’s director compensation program instead of receiving retainer fees in cash.

How many Omada Health (OMDA) shares does Jeryl Hilleman hold after this Form 4?

After this grant, Jeryl Hilleman holds 26,519 shares of Omada Health common stock directly. This total includes the impact of the newly awarded 1,299 restricted stock units disclosed in the reported transaction.

What are the key terms of the RSUs granted to the Omada Health (OMDA) director?

Each restricted stock unit represents the right to receive one share of Omada Health common stock. Settlement will occur on a date Jeryl Hilleman selects under the director compensation program or as otherwise provided by that program’s terms.

Why did Omada Health (OMDA) grant RSUs in lieu of retainer fees?

The company’s Non-Employee Director Compensation Program allows directors to receive equity instead of cash retainer fees. In this case, Jeryl Hilleman received 1,299 restricted stock units, aligning a portion of her compensation with Omada Health’s common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HILLEMAN JERYL L

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/05/2026		A		1,299(1)	A	$0	26,519	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

	/s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)